Presentations
2021
Immunovia Key Opinion Leader Event on the Clinical Use of IMMray™ PanCan-d, June 10, 2021
Panel discussion participants:
- Stephen Pereira, Professor of Hepatology and Gastroenterology, University College London
- James Farrell, Professor of Medicine at Yale School of Medicine and Director of the Yale Center for Pancreatic Diseases at Yale New Haven Health
- Geoffrey Burns, MD, FAAFP, Renaissance Family Medicine of Wellesley, Massachusetts, USA
Moderator for the panel discussion: Dr. Thomas King, Medical Director, Immunovia Inc.
Corporate overview presented by Patrik Dahlen, CEO Immunovia.
2020
Immunovia Webinar Introducing New CEO, Patrik Dahlen with Chairman, Carl Borrebaeck, followed by a Q&A session, November 3, 2020
H.C. Wainwright 22nd Annual Global Investment Conference, September 14, 2020
Weblink to Immunovia presentation – 2020-09-14
Immunovia’s Virtual Investor Day, June 30 2020
The online event features presentations by Immunovia’s Chairman, Carl Borrebaeck; CEO, Mats Grahn; Chief Commercial Officer, Laura Chirica; Senior VP Sales North America, Michael Pettigrew; and Dr Thomas King, Medical Director, followed by a Q&A session.
Immunovia Presentation – PDF version
Immunovia Corporate presentation, May 2020
Immunovia Corporate Presentation – PDF version
2019
Presentation from Vator Securities Unicorn Summit, Stockholm, Sweden, November 27, 2019
Vator Securities Unicorn Summit was held November 27, 2019 in Stockholm. Click below to see the presentation film with Mats Grahn, CEO of Immunovia (in Swedish).
Immunovia Presentation – 2019-11-27
Presentation from Vator Securities Unicorn Summit, Stockholm, Sweden, March 21, 2019
Vator Securities Unicorn Summit was held March 21, 2019 in Stockholm. Click below to see the presentation film with Mats Grahn, CEO of Immunovia.
Immunovia Presentation – 2019-03-21
2018
Presentation from World Pancreatic Cancer Day 2018, Fenway Park, Boston, November 15, 2018
Presentation from Vator Securities Unicorn Summit, Medicon Village Lund, October 10, 2018
Vator Securities Unicorn Summit was held October 10, 2018 at Medicon Village in Lund. Click below to see the presentation film with Mats Grahn, CEO of Immunovia and Henrik Winther, SVP Business Development Immunovia.
Immunovia Presentation – 2018-10-10
Presentation from Vator Securities Unicorn Summit, Stockholm, May 8, 2018
Vator Securities Unicorn Summit was held May 8, 2018 in Stockholm. Click below to see the presentation film with Mats Grahn, CEO of Immunovia (in Swedish).
Link to presentation (in Swedish) – 2018-05-08
Nasdaq Stockholm welcomes Immunovia to the main market, April 3, 2018
Mats Grahn, CEO, was presenting Immunovia at BioStock Live on March 20, 2018
Link to the presentation (in English) – 2018-03-20
Interview with CEO Mats Grahn (in Swedish) – 2018-03-20
2017
Mats Grahn, CEO, was presenting Immunovia at The Redeye Life Science Seminar on November 24, 2017
Link to the presentation – 2017-11-24
Presentation from Vator Securities Unicorn Summit, Stockholm, November 14, 2017
Vator Securities Unicorn Summit was held November 14, 2017 in Stockholm. Click below to see the presentation film with Mats Grahn, CEO of Immunovia.
Immunovia presentation – 2017-11-14
Presentation from Vator Securities Unicorn Summit, Stockholm, March 7, 2017
Vator Securities Unicorn Summit was held March 7, 2017 in Stockholm. Click below to see the presentation film with Mats Grahn, CEO of Immunovia and Prof Carl Borrebaeck.
Immunovia presentation – 2017-03-07
Immunovia presentation from Oslo Life Science 2017, Feb. 16
PhD Laura Chirica, CCO at Immunovia, held a talk with the title: “Diagnosis of early stages of pancreatic cancer”.
Link to the presentation from Oslo Life Science 2017 – 2017-02-16
Immunovia presentation from Oslo Life Science 2017, Feb. 16
Diagnosis of early stages of pancreatic cancer – Laura Chirica, CCO, Immunovia AB
2016
Interview with Mats Grahn, CEO Immunovia by Avanza, December 13, 2016. “Lär känna” Immunovia.
“Lär känna” Immunovia – 2016-12-13
Interview with Immunovia, Winner of Star of Innovation 2016. Mats Grahn, CEO Immunovia being interviewed after the Small & Midcap Awards ceremony in Brussels, Belgium, November 17, 2016
Interview with Immunovia – 2016-11-17
Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
Pancreatic cancer overview and how to improve survival rates – Prof. Marco Del Chiaro; Karolinska University Hospital, Sweden.
Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
IMMray™ Biomarker signatures history and development – Prof Carl Borrebaeck, CREATE Health, Lund
Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
Pancreatic cancer – from a patient perspective – PALEMA, Swedish patient support organization, Carl Hamilton
Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
Pancreatic cancer – from a patient perspective – Pancreasnetværket, Danish patient organization, Poul Ejby Rasmussen
Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
Early detection of pancreatic cancer with IMMray™ PanCan-d – PhD. Laura Chirica, CCO, Immunovia AB
World Pancreatic Cancer Day Lund Sweden, November 17, 2016:
We united and made our voices heard in the battle against pancreatic cancer during ”World pancreatic cancer day”
Presentation from Vator Securities Unicorn Summit, Stockholm, September 13, 2016
Vator Securities Unicorn Summit was held September 13, 2016 in Stockholm. Click below to see the presentation film with Mats Grahn, CEO of Immunovia and Prof Carl Borrebaeck.
PharmaTV interview with Mats Grahn, CEO Immunovia, from BIO-Europe Spring in Stockholm in April 2016
Immunovia: diagnosing pancreatic cancer from one drop of blood
Presentation from Shareholder Day in Copenhagen, April 12, 2016
Immunovia presented by Mats Grahn, CEO
Presentation films from Vator Securities Unicorn Summit, Stockholm, March 9, 2016
Vator Securities Unicorn Summit was held March 9, 2016 and was attended by more than 150 participants. Click below to see the presentation films with Prof Carl Borrebaeck as a secret guest, and with Mats Grahn, CEO of Immunovia, presenting the company and its plans going forward.
